Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...

Study reveals how c-stores are increasingly competitive with quick service. Convenience stores are becoming more competitive with quick-service restaurants as consumers’ perceptions of quality and ...

Consumers' expectations shifted in March toward greater inflation over the next year, according to the New York Fed's monthly survey. But their views of expected longer-run inflation didn't increase, ...